Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 TrialBenedito A. Carneiro(Northwestern University), Francis J. Giles(Northwestern University)The Journal of Clinical Endocrinology & MetabolismJuly 5, 201910.1210/jc.2019-00600Cited by 116SaveCiteExport RISWatch citationsRelated PapersCurrent landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)|Journal for ImmunoTherapy of Cancer|2018|467